Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents.
Blood Cancer J
; 7(5): e562, 2017 05 12.
Article
in En
| MEDLINE
| ID: mdl-28498370
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Azacitidine
/
Leukemia, Myelomonocytic, Chronic
/
Antimetabolites, Antineoplastic
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood Cancer J
Year:
2017
Document type:
Article